Amdocs (NASDAQ: DOX) reported Q2 EPS of $0.92, $0.05 better than the analyst estimate of $0.87. Revenue for the quarter came in at $926 million versus the consensus estimate of $925.32 million.

GUIDANCE:

Amdocs sees Q3 2016 EPS of $0.84-$0.90, versus the consensus of $0.90. Amdocs sees Q3 2016 revenue of $910-950 million, versus the consensus of $936.7 million.

Reiterates FY16 Non-GAAP Diluted EPS Growth Outlook of 3.5%-7.5% YoY

For earnings history and earnings-related data on Amdocs (DOX) click here.